Company Filing History:
Years Active: 2018-2024
Title: Denise Kottwitz: Innovator in Cancer Diagnostics
Introduction
Denise Kottwitz is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmacogenomics, particularly in the detection of CpG methylation for cancer diagnosis. With a total of 3 patents to her name, Kottwitz is recognized for her innovative approaches to improving cancer diagnostics.
Latest Patents
One of Kottwitz's latest patents focuses on methods for detecting CpG methylation and diagnosing cancer. This invention relates to the detection of hypermethylated DNA, which is crucial for identifying various cancers. The improved methods she developed allow for more sensitive detection of methylated marker DNA, even in the presence of high backgrounds of unmethylated marker DNA. This advancement has the potential to enhance diagnostic accuracy and patient outcomes.
Career Highlights
Throughout her career, Denise Kottwitz has worked with notable companies in the biotechnology sector. She has been associated with Epigenomics AG and New Day Diagnostics, LLC, where she has applied her expertise in developing innovative diagnostic methods. Her work has significantly impacted the field of cancer research and diagnostics.
Collaborations
Kottwitz has collaborated with several professionals in her field, including Anne Schlegel and Reimo Tetzner. These collaborations have furthered her research and contributed to the development of her patented technologies.
Conclusion
Denise Kottwitz is a trailblazer in the realm of cancer diagnostics, with her innovative methods for detecting CpG methylation paving the way for improved diagnostic techniques. Her contributions to pharmacogenomics continue to influence the field and enhance patient care.